This inventor holds 1 USPTO granted patent. Top assignee: Merck Patent Gmbh. Active years: 2007.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2007
Title: The Innovations of Hans-Micahel Eggenweiler
Introduction
Hans-Micahel Eggenweiler is a notable inventor based in Darmstadt, Germany. He has made significant contributions to the field of pharmaceuticals, particularly in the development of compounds that can aid in the treatment of cardiovascular diseases and potency disorders.
Latest Patents
Eggenweiler holds a patent for pyrimidine derivatives, which are defined by the formula (I) and include physiologically acceptable salts. These compounds exhibit phosphodiesterase V inhibition, making them valuable in the treatment of various cardiovascular conditions and potency disorders.
Career Highlights
He is currently associated with Merck Patent GmbH, where he continues to innovate and contribute to the pharmaceutical industry. His work has been instrumental in advancing therapeutic options for patients suffering from cardiovascular issues.
Collaborations
Throughout his career, Eggenweiler has collaborated with esteemed colleagues such as Manfred Baumgarth and Pierre Schelling, further enhancing the impact of his research and inventions.
Conclusion
Hans-Micahel Eggenweiler's contributions to the field of pharmaceuticals through his innovative patents demonstrate his commitment to improving healthcare solutions. His work continues to influence the treatment of significant medical conditions.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile